Vanguard Group
PLXP

Vanguard Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Vanguard Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-289,094
Closed -$37.6K – 4628
2023
Q1 		$37.6K Sell
289,094
-49,428
-15% -$10.1K ﹤0.01% 4495
2022
Q4 		$55.6K Sell
338,522
-777,284
-70% -$325K ﹤0.01% 4437
2022
Q3 		$726K Buy
1,115,806
+14,954
+1% +$22K ﹤0.01% 4096
2022
Q2 		$2.67M Hold
1,100,852
– – ﹤0.01% 3680
2022
Q1 		$4.45M Sell
1,100,852
-42,493
-4% -$233K ﹤0.01% 3590
2021
Q4 		$9.16M Sell
1,143,345
-1,477
-0.1% -$17.3K ﹤0.01% 3269
2021
Q3 		$22.1M Buy
1,144,822
+197,521
+21% +$3.45M ﹤0.01% 2814
2021
Q2 		$13.1M Buy
947,301
+38,665
+4% +$458K ﹤0.01% 3069
2021
Q1 		$8.21M Buy
908,636
+614,041
+208% +$4.49M ﹤0.01% 3262
2020
Q4 		$1.63M Hold
294,595
– – ﹤0.01% 3712
2020
Q3 		$952K Hold
294,595
– – ﹤0.01% 3668
2020
Q2 		$954K Hold
294,595
– – ﹤0.01% 3625
2020
Q1 		$663K Hold
294,595
– – ﹤0.01% 3608
2019
Q4 		$1.29M Hold
294,595
– – ﹤0.01% 3571
2019
Q3 		$1.5M Buy
294,595
+148,946
+102% +$867K ﹤0.01% 3536
2019
Q2 		$1.05M Buy
145,649
+32,874
+29% +$178K ﹤0.01% 3662
2019
Q1 		$592K Buy
112,775
+17,300
+18% +$84.6K ﹤0.01% 3743
2018
Q4 		$146K Sell
95,475
-67,956
-42% -$242K ﹤0.01% 3943
2018
Q3 		$662K Buy
163,431
+80,910
+98% +$304K ﹤0.01% 3805
2018
Q2 		$326K Buy
82,521
+62
+0.1% +$253 ﹤0.01% 3904
2018
Q1 		$276K Buy
82,459
+25,931
+46% +$164K ﹤0.01% 3910
2017
Q4 		$390K Buy
56,528
+21,027
+59% +$146K ﹤0.01% 3801
2017
Q3 		$231K Buy
+35,501
New +$228K ﹤0.01% 3888
2017
Q2 		– Sell
-14,371
Closed -$150K – 4087
2017
Q1 		$150K Hold
14,371
– – ﹤0.01% 3947
2016
Q4 		$184K Sell
14,371
-7,314
-34% -$269K ﹤0.01% 3903
2016
Q3 		$2.52M Buy
21,685
+1,898
+10% +$185K ﹤0.01% 3304
2016
Q2 		$1.57M Buy
19,787
+1,584
+9% +$137K ﹤0.01% 3462
2016
Q1 		$1.39M Buy
18,203
+978
+6% +$62.2K ﹤0.01% 3497
2015
Q4 		$1.54M Buy
17,225
+4,753
+38% +$456K ﹤0.01% 3493
2015
Q3 		$1.4M Buy
12,472
+824
+7% +$94.8K ﹤0.01% 3527
2015
Q2 		$1.19M Buy
11,648
+5,140
+79% +$532K ﹤0.01% 3615
2015
Q1 		$710K Buy
6,508
+1,909
+42% +$195K ﹤0.01% 3724
2014
Q4 		$419K Buy
4,599
+1,026
+29% +$87.5K ﹤0.01% 3782
2014
Q3 		$284K Buy
+3,573
New +$273K ﹤0.01% 3836

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Vanguard Group's PLXP Position: Q2 2023 in Review

Vanguard Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 289,094 shares — an estimated $37.6K sold.

Vanguard Group first reported a position in PLXP in Q3 2014 and held it in 34 quarters. The position peaked at $22.1M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Vanguard Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Vanguard Group sold 289,094 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
  • Vanguard Group first reported a position in PLx Pharma Inc. Common Stock in Q3 2014 and held it in 34 quarters.
  • Vanguard Group's PLx Pharma Inc. Common Stock position peaked at $22.1M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.